p53-based cancer therapy.
Inactivation of p53 functions is an almost universal feature of human cancer cells. This has spurred a tremendous effort to develop p53 based cancer therapies. Gene therapy using wild-type p53, delivered by adenovirus vectors, is now in widespread use in China. Other biologic approaches include the development of oncolytic viruses designed to replicate and kill only p53 defective cells and also the development of siRNA and antisense RNA's that activate p53 by inhibiting the function of the negative regulators Mdm2, MdmX, and HPV E6. The altered processing of p53 that occurs in tumor cells can elicit T-cell and B-cell responses to p53 that could be effective in eliminating cancer cells and p53 based vaccines are now in clinical trial. A number of small molecules that directly or indirectly activate the p53 response have also reached the clinic, of which the most advanced are the p53 mdm2 interaction inhibitors. Increased understanding of the p53 response is also allowing the development of powerful drug combinations that may increase the selectivity and safety of chemotherapy, by selective protection of normal cells and tissues.
Lane
David P
DP
p53 Laboratory (A-Star) 8A Biomedical Grove Immunos Singapore 138648. dplane@p53lab.a-star.edu.sg
Cheok
Chit Fang
CF
Lain
Sonia
S
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D034741:RNA, Small Interfering / Q000008:administration & dosage; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
D019496:Cancer Vaccines; D034741:RNA, Small Interfering; D016159:Tumor Suppressor Protein p53; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2
Cell Death Differ. 2008 Feb;15(2):263-73
17975552
Nat Cell Biol. 2007 Oct;9(10):1175-83
17891139
Science. 1999 Oct 29;286(5441):971-4
10542155
J Biol Chem. 2001 Oct 19;276(42):38837-43
11483616
Nat Chem Biol. 2006 Apr;2(4):202-6
16474381
Oncogene. 2005 May 12;24(21):3484-91
15735745
Adv Cancer Res. 2009;102:171-95
19595309
Curr Opin Mol Ther. 2009 Oct;11(5):547-53
19806503
Nature. 2007 Feb 8;445(7128):661-5
17251932
J Virol. 2005 Jul;79(14):8773-83
15994771
Cell. 2008 Nov 28;135(5):907-18
19041753
PLoS One. 2008 Apr 16;3(4):e2020
18414679
Nat Biotechnol. 1998 May;16(5):440-3
9592391
Cancer Lett. 2008 Sep 28;269(1):127-38
18534745
Mol Cell Biol. 1998 Dec;18(12):7288-93
9819415
Cancer Cell. 2008 Oct 7;14(4):312-23
18835033
J Am Chem Soc. 2007 Mar 7;129(9):2456-7
17284038
Nat Med. 2002 Mar;8(3):282-8
11875500
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61
17015838
Nat Rev Drug Discov. 2008 Oct;7(10):841-53
18827827
Nature. 2008 Oct 2;455(7213):679-83
18716624
FASEB J. 2003 Sep;17(12):1622-30
12958168
Oncogene. 2008 Nov 20;27(51):6571-80
18663359
Science. 1996 Nov 8;274(5289):948-53
8875929
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10360-5
18650397
Cancer Res. 2009 Jan 15;69(2):510-7
19147564
Cell Cycle. 2008 Nov 1;7(21):3417-27
18971638
Oncogene. 2008 Sep 11;27(40):5303-14
18521084
Oncogene. 2002 Mar 28;21(14):2119-29
11948395
Science. 2004 Feb 6;303(5659):844-8
14704432
Cancer Res. 2008 Sep 15;68(18):7670-5
18794156
Nat Med. 2004 Dec;10(12):1321-8
15558054
Nature. 2009 Nov 12;462(7270):182-8
19907488
Nature. 1995 Nov 9;378(6553):203-6
7477326
J Natl Cancer Inst. 1996 Jun 19;88(12):802-11
8637046
Clin Cancer Res. 1996 Feb;2(2):269-76
9816169
Nature. 2005 Apr 14;434(7035):917-21
15829967
Oncogene. 2000 Jan 13;19(2):232-40
10645001
Nature. 2008 Jan 31;451(7178):587-90
18235502
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16958-63
18952844
Exp Cell Res. 1999 May 1;248(2):457-72
10222137
Clin Cancer Res. 1999 Nov;5(11):3345
10589741
Oncogene. 2001 May 31;20(25):3206-16
11423970
Int J Cancer. 2005 Jul 10;115(5):701-10
15729694
Cell. 2001 Oct 19;107(2):149-59
11672523
J Med Chem. 2006 Jun 15;49(12):3432-5
16759082
Int J Biochem Cell Biol. 2010 May;42(5):725-35
20080206
Cancer Cell. 2003 Nov;4(5):371-81
14667504
Oncogene. 2009 Feb 12;28(6):781-91
19060927
Nat Cell Biol. 2000 Sep;2(9):563-8
10980695
Cancer Cell. 2005 Jul;8(1):61-74
16023599
Cell. 1992 Jun 26;69(7):1237-45
1535557
Oncogene. 2000 May 4;19(19):2312-23
10822382
Biochem Biophys Res Commun. 2000 Jul 5;273(2):793-8
10873683
Clin Cancer Res. 2009 Feb 1;15(3):1086-95
19188184
Cancer Res. 2002 Jun 15;62(12):3521-9
12067999
Br J Cancer. 1996 Aug;74(4):648-9
8761384
Anticancer Drugs. 2009 Jun;20(5):403-7
19318914
Oncogene. 2008 Feb 7;27(7):997-1003
17700533
Cell. 2001 Oct 19;107(2):137-48
11672522
PLoS Genet. 2006 Mar;2(3):e40
16596166
Cell Cycle. 2009 Sep 1;8(17):2810-8
19657224
Science. 2001 Jun 8;292(5523):1910-5
11397945
J Med Chem. 2005 Dec 15;48(25):8045-54
16335928
Cell. 2008 May 16;133(4):612-26
18485870
Somat Cell Mol Genet. 1987 May;13(3):235-44
3474784
Circ Res. 2008 Mar 28;102(6):703-10
18239138
Genes Dev. 2006 Nov 1;20(21):2913-21
17079682
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6302-7
18424558
J Biol Chem. 2002 Aug 9;277(32):28446-58
11925449
Exp Cell Res. 2003 Jun 10;286(2):321-31
12749860
Cancer Res. 2005 Mar 1;65(5):1918-24
15753391
J Mol Cell Cardiol. 2007 Nov;43(5):571-9
17916362
Oncogene. 1995 May 4;10(9):1865-8
7753562
Blood. 2008 Feb 1;111(3):1584-93
17971485
Br J Cancer. 2003 Feb 24;88(4):636-43
12592381
Oncogene. 1999 Dec 2;18(51):7378-86
10602494
J Biol Chem. 2007 Jul 6;282(27):19546-55
17488717
Exp Cell Res. 2002 Jun 10;276(2):214-22
12027451
Int J Oncol. 2009 May;34(5):1395-402
19360352
Mol Cell. 2003 Feb;11(2):437-44
12620231
Cancer Res. 2006 Dec 15;66(24):11817-24
17178878
Oncogene. 1996 Nov 21;13(10):2141-7
8950981
Biochem Pharmacol. 1999 Jun 1;57(11):1283-95
10230772
Cancer Res. 2004 May 15;64(10):3653-60
15150125
Cell Cycle. 2004 Apr;3(4):419-21
15004525
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2259-64
14982997
Science. 1996 Oct 18;274(5286):373-6
8832876
Oncogene. 1994 Sep;9(9):2523-9
8058315
Cancer Cell. 2008 May;13(5):454-63
18455128
Mol Cancer Ther. 2007 May;6(5):1478-82
17483435
Cancer Res. 2007 Jul 15;67(14):6612-8
17638871
Genes Dev. 2006 Jan 1;20(1):16-21
16391230
Cancer Res. 2006 Nov 1;66(21):10274-80
17079445
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3933-8
18316739
Int J Cancer. 2009 Apr 15;124(8):1829-40
19117056
Curr Opin Chem Biol. 2008 Feb;12(1):11-7
18282481
Oncogene. 2008 May 29;27(24):3371-83
18223694
Exp Cell Res. 2009 Feb 1;315(3):451-61
19071110
Cancer Res. 2009 Sep 1;69(17):6899-905
19690141
Cell Cycle. 2009 May 15;8(10):1630-2
19372763
Hum Gene Ther. 2008 Sep;19(9):873-86
18710328
Biochem Biophys Res Commun. 2003 Sep 26;309(3):558-66
12963026
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10794-9
12960381
Mol Cell Biol. 2001 Dec;21(24):8521-32
11713287
Radiother Oncol. 2008 Mar;86(3):407-11
18237796
Int J Cancer. 2007 Jun 1;120(11):2317-24
17290384
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8501-6
10900010
Cancer Res. 2005 Nov 15;65(22):10457-63
16288037
Int J Biochem Cell Biol. 2007;39(7-8):1476-82
17499002
Arch Dermatol Res. 2007 May;299(2):103-6
17180656
Biochem Biophys Res Commun. 2007 Jan 5;352(1):203-12
17113036
Cell Death Differ. 2010 Sep;17(9):1486-500
20203688
Genes Dev. 1993 Jul;7(7A):1126-32
8319905
EMBO J. 1999 Aug 16;18(16):4424-37
10449408
Mol Cell Biol. 2003 Mar;23(6):2171-81
12612087
Hum Gene Ther. 2007 Feb;18(2):118-29
17328684
Cancer Res. 2006 Apr 15;66(8):4368-77
16618762
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4665-70
19255450
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3964-9
19225112
Nat Med. 1996 Sep;2(9):985-91
8782455
Mol Cell Biol. 2009 Apr;29(8):2243-53
19223463
Mol Cell Biol. 2006 Jan;26(1):28-38
16354677
Nat Rev Cancer. 2009 Feb;9(2):123-8
19132007
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11003-8
16835297
Cancer Cell. 2009 May 5;15(5):376-88
19411067
Mol Cancer Res. 2007 Nov;5(11):1133-45
18025259
Oncogene. 2002 Sep 5;21(39):6041-8
12203116
Biotechnol J. 2007 Nov;2(11):1360-8
17806102
Cancer Cell. 2004 Dec;6(6):611-23
15607965
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15113-8
11752457
Cancer Cell. 2009 Nov 6;16(5):369-77
19878869
J Biol Chem. 2010 Apr 2;285(14):10786-96
20080970
EMBO J. 1993 Feb;12(2):461-8
8440237
Cancer Chemother Pharmacol. 1986;16(2):95-101
3081269
Mol Cell Biol. 1993 Jul;13(7):4107-14
7686617
Mol Cell Biol. 2007 Feb;27(3):1056-68
17116689
Cancer Cell. 2006 Dec;10(6):501-14
17157790
Oncogene. 2009 Jan 22;28(3):445-60
18850005
Cell Cycle. 2010 Feb 1;9(3):540-7
20081368
Genes Dev. 1996 Apr 15;10(8):934-47
8608941
Methods Mol Biol. 2003;234:211-7
12824534
J Pharmacol Sci. 2008 Nov;108(3):364-71
19008647
Biochem Biophys Res Commun. 2006 Jan 6;339(1):71-8
16297858
Mol Pharmacol. 1999 Sep;56(3):478-84
10462535
Science. 1999 Dec 24;286(5449):2507-10
10617466
Nature. 2007 Feb 8;445(7128):656-60
17251933
Cell. 2006 Dec 29;127(7):1323-34
17182091
Cell Cycle. 2005 Nov;4(11):1510-4
16294017
Cancer Res. 2008 Feb 1;68(3):893-900
18245492
Cancer Cell. 2009 Mar 3;15(3):171-83
19249676
EMBO J. 1999 Mar 15;18(6):1660-72
10075936
Biochem J. 2007 May 15;404(1):1-13
17447894
Exp Cell Res. 2001 Oct 15;270(1):66-77
11597128
Int J Oncol. 2009 Sep;35(3):649-56
19639186
Nat Cell Biol. 2000 Sep;2(9):569-73
10980696
Endocr Relat Cancer. 2009 Mar;16(1):85-98
19075036
Leukemia. 2005 Oct;19(10):1751-9
16121216
Curr Biol. 1997 Nov 1;7(11):860-9
9382809
Clin Immunol. 2007 Oct;125(1):43-51
17631051
Crit Rev Immunol. 1998;18(1-2):29-35
9419445
J Clin Invest. 2007 Dec;117(12):3658-60
18060027
J Med Chem. 2005 Feb 24;48(4):909-12
15715460
Curr Cancer Drug Targets. 2005 Feb;5(1):43-9
15720188
EMBO J. 2002 May 15;21(10):2383-96
12006491
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3025-9
1313577
Structure. 2007 Mar;15(3):377-89
17355872
Oncogene. 2007 May 24;26(24):3473-81
17146434